Hippocampal Radiation Exposure and Memory
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Neurocognitive impairment as a result of gamma knife radiosurgery has not been well studied and is poorly understood. Radiosurgery to the base of skull for the treatment of benign and malignant disorders may consequently impair memory function. There is a need to evaluate changes in memory function that may be associated with such exposures.
In this pilot study, we will investigate changes in hippocampal-dependent memory function in 10 patients receiving a low SRS dose to the hippocampus. We will also investigate such changes in a no-dose control group and a high-dose control group. This study will provide preliminary estimates of variance in memory changes associated with radiation exposure, and will then permit us to design future studies with the appropriate sample size justification.
| Condition |
|---|
|
Arteriovenous Malformation Schwannoma Trigeminal Neuralgia |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Hippocampal Radiation Exposure and Memory: A Pilot Study |
| Estimated Enrollment: | 30 |
| Study Start Date: | September 2007 |
| Groups/Cohorts |
|---|
|
1
(Experimental group): Receiving > 2 Gy SRS to left hippocampus (n=10)
|
|
2
(Low-dose control group): Receiving < 0.5 Gy SRS to left hippocampus (n=10)
|
|
3
(High-dose control group): Receiving whole brain PCI (n=10)
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients who have consented to GK radiosurgery or cranial radiation.
Inclusion Criteria:
- Patients planned for radiosurgery for benign disorders (Groups 1&2).
- Patients planned for prophylactic cranial irradiation (Group 3)
Exclusion Criteria:
- Previous cranial radiation
- Severe psychiatric disorder
- Severe cognitive or memory impairment (MMSE < 21)
- Non-English speaking, which will potentially make memory testing difficult and unreliable.
- Other medical conditions deemed by the PI or associates to make the patient ineligible for protocol procedures
- Patients on steroid medications.
- Left hand dominant patients
- Dose exposure to left hippocampus >0.5Gy and <2Gy. We will attempt to estimate dose to hippocampus prior to enrollment using pre-planning on diagnostic imaging to minimize exclusion of patients due to dose exposure >0.5 Gy and < 2Gy following baseline memory testing.
- Benzodiazepine or narcotics given on the day of radiotherapy/radiosurgery prior to completion of the study procedures
- Previous brain surgery within one year prior to radiosurgery
- Pregnant women
Contacts and Locations| Contact: Heather Sharpe, B.Sc. | 416-603-5445 | heather.sharpe@rmp.uhn.on.ca |
| Canada, Ontario | |
| Joey & Toby Tanenbaum Gamma Knife Centre, Toronto Western Hospital | Recruiting |
| Toronto, Ontario, Canada, M5T 2S8 | |
| Principal Investigator: Cynthia Menard, Docorate | |
| Sub-Investigator: Iwa Kong | |
More Information
No publications provided
| Responsible Party: | Dr. Cynthia Menard, University Health Network |
| ClinicalTrials.gov Identifier: | NCT00603694 History of Changes |
| Other Study ID Numbers: | 07-0023-CE |
| Study First Received: | January 16, 2008 |
| Last Updated: | January 9, 2009 |
| Health Authority: | Canada: Health Canada |
Keywords provided by University Health Network, Toronto:
|
Hippocampus Memory Radiation |
Additional relevant MeSH terms:
|
Arteriovenous Malformations Congenital Abnormalities Aneurysm Hemangioma Neuralgia Neurilemmoma Trigeminal Neuralgia Vascular Malformations Cardiovascular Abnormalities Cardiovascular Diseases Vascular Diseases Neoplasms, Vascular Tissue Neoplasms by Histologic Type Neoplasms Pain |
Neurologic Manifestations Nervous System Diseases Peripheral Nervous System Diseases Neuromuscular Diseases Signs and Symptoms Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Nerve Sheath Neoplasms Neoplasms, Nerve Tissue Neuroma Peripheral Nervous System Neoplasms Nervous System Neoplasms Trigeminal Nerve Diseases Cranial Nerve Diseases |
ClinicalTrials.gov processed this record on May 19, 2013